InMode

Company Overview

Snapshot

Founded in January 2008 by Moshe Mizrahy, InMode operates with over 500 employees. The company has raised $70 million across one funding round and went public on NASDAQ in August 2019.

Business overview

InMode is a global provider of energy-based minimally invasive and noninvasive aesthetic solutions, leveraging medically accepted radio-frequency (RF) energy technology. Its products are designed to penetrate deep into the subdermal fat layer for adipose tissue remodeling. Physicians utilize InMode's technologies for various procedures, including liposuction with simultaneous skin tightening, face and body contouring, and ablative skin rejuvenation treatments, serving the health tech and life sciences sector with solutions like BodyTite, Optimas, Votiva, Contoura, EmbraceRF, Evoke, Evolve, and Triton workstations.

Strategic signal

In September 2025, DOMA Perpetual sent a letter urging. This signals a potential shift in the company's financial strategy towards shareholder returns, which could impact future investment decisions and operational priorities.

Company Intelligence Q&A

When did InMode become a public company?

InMode became a public company with an Initial Public Offering on NASDAQ in August 2019.

What was InMode's total capital raised through public offerings?

InMode raised $70 million through its public offering.

What was a key strategic move by InMode in July 2023?

In July 2023, InMode expanded its women's health and wellness market footprint through the acquisition of Viveve Medical's patents.

What was a notable investor action concerning InMode in September 2025?

In September 2025, DOMA Perpetual sent a letter urging InMode's Board of Directors to return capital to the shareholders.

What was a significant announcement from InMode in September 2024?

In September 2024, InMode announced a share repurchase program of up to 7.68 million shares.